Multiparameter urine analysis for quantitative bladder cancer surveillance of orthotopic xenografted mice
- 3 January 2020
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 20 (3) , 634-646
Abstract
The human-derived orthotopic xenograft mouse model is an effective platform for performing in vivo bladder cancer studies to examine tumor development, metastasis, and therapeutic effects of drugs. To date, the surveillance of tumor progression in real time for orthotopic bladder xenografts is highly dependent on semi-quantitative in vivo imaging technologies such as bioluminescence. While these imaging technologies can estimate tumor progression, they are burdened with requirements such as anesthetics, specialized equipment, and genetic modification of the injected cell line. Thus, a convenient and non-invasive technology to quantitatively monitor the growth of bladder cancer in orthotopic xenografts is highly desired. In this work, using a microfluidic chemiluminescent ELISA platform, we have successfully developed a rapid, multiparameter urine-based and non-invasive biomolecular prognostic technology for orthotopic bladder cancer xenografts. This method consists of two steps. First, the concentrations of a panel of four urinary biomarkers are quantified from the urine of mice bearing orthotopic bladder xenografts. Second, machine learning and principal component analysis (PCA) algorithms are applied to analyze the urinary biomarkers, and subsequently, a score is assigned to indicate the tumor growth. With this methodology, we have quantitatively monitored the orthotopic growth of human bladder cancer that was inoculated with low, medium, and high cancer cell numbers. We also employed this method and performed a proof of principle experiment to examine the in vivo therapeutic efficacy of the EGFR inhibitor, dacomitinib.Keywords
Funding Information
- National Science Foundation (DBI-1451127)
- National Science Foundation (ECCS-1607250)
This publication has 49 references indexed in Scilit:
- Ultrasound-Guided Intramural Inoculation of Orthotopic Bladder Cancer Xenografts: A Novel High-Precision ApproachPLOS ONE, 2013
- Bioluminescence imaging: looking beyond the lightTrends in Molecular Medicine, 2012
- Urinary Biomarkers for the Early Diagnosis of Kidney CancerMayo Clinic Proceedings, 2010
- Firefly Luciferase–Based Dynamic Bioluminescence ImagingNeurosurgery, 2010
- Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: results in 1005 patientsAnnals of Oncology, 2009
- Mouse orthotopic models for bladder cancer researchBJU International, 2009
- Can urinary exosomes act as treatment response markers in prostate cancer?Journal of Translational Medicine, 2009
- The Ectodomain Shedding of E-cadherin by ADAM15 Supports ErbB Receptor ActivationJournal of Biological Chemistry, 2008
- HER2 overexpression in muscle‐invasive urothelial carcinoma of the bladder: Prognostic implicationsInternational Journal of Cancer, 2002
- EGFR and cancer prognosisEuropean Journal of Cancer, 2001